BRPI0711310B8 - composto inibidor de p38 map cinase, composição farmacêutica compreendendo o mesmo e uso do mesmo - Google Patents
composto inibidor de p38 map cinase, composição farmacêutica compreendendo o mesmo e uso do mesmoInfo
- Publication number
- BRPI0711310B8 BRPI0711310B8 BRPI0711310A BRPI0711310A BRPI0711310B8 BR PI0711310 B8 BRPI0711310 B8 BR PI0711310B8 BR PI0711310 A BRPI0711310 A BR PI0711310A BR PI0711310 A BRPI0711310 A BR PI0711310A BR PI0711310 B8 BRPI0711310 B8 BR PI0711310B8
- Authority
- BR
- Brazil
- Prior art keywords
- map kinase
- radical
- optionally substituted
- formula
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title abstract 3
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title abstract 3
- 229940122696 MAP kinase inhibitor Drugs 0.000 title abstract 2
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000002843 carboxylic acid group Chemical group 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 108090000371 Esterases Proteins 0.000 abstract 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract 1
- 235000008206 alpha-amino acids Nutrition 0.000 abstract 1
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0608855A GB0608855D0 (en) | 2006-05-04 | 2006-05-04 | Inhibitors of MAP kinase enzymes |
| GB0608855.3 | 2006-05-04 | ||
| GB0613914.1 | 2006-07-13 | ||
| GB0613914A GB0613914D0 (en) | 2006-07-13 | 2006-07-13 | Inhibitors of p38 map kinase |
| PCT/GB2007/001596 WO2007129040A1 (en) | 2006-05-04 | 2007-05-01 | p38 MAP KINASE INHIBITORS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0711310A2 BRPI0711310A2 (pt) | 2011-12-06 |
| BRPI0711310B1 BRPI0711310B1 (pt) | 2020-12-15 |
| BRPI0711310B8 true BRPI0711310B8 (pt) | 2021-05-25 |
Family
ID=38268953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0711310A BRPI0711310B8 (pt) | 2006-05-04 | 2007-05-01 | composto inibidor de p38 map cinase, composição farmacêutica compreendendo o mesmo e uso do mesmo |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8044211B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2013175B9 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5340918B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101429780B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102942520B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007246869B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0711310B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2650970C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1118518T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2013175T5 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2605727T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE033281T2 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ573348A (cg-RX-API-DMAC7.html) |
| PT (1) | PT2013175T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007129040A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0619753D0 (en) | 2006-10-06 | 2006-11-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
| EA017198B1 (ru) * | 2006-10-30 | 2012-10-30 | Хрома Терапьютикс Лтд. | Гидроксаматы в качестве ингибиторов гистон-деацетилазы |
| CN101842361B (zh) | 2007-06-27 | 2013-06-05 | 阿斯利康(瑞典)有限公司 | 吡嗪酮衍生物及其在治疗肺病中的用途 |
| JP2011503042A (ja) * | 2007-11-07 | 2011-01-27 | クロマ セラピューティクス リミテッド | ｐ３８ＭＡＰキナーゼ阻害剤 |
| EP2245012B1 (en) | 2008-02-29 | 2013-07-03 | Chroma Therapeutics Limited | Inhibitors of p38 map kinase |
| GB0803747D0 (en) | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
| US8304413B2 (en) | 2008-06-03 | 2012-11-06 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
| AR073711A1 (es) | 2008-10-01 | 2010-11-24 | Astrazeneca Ab | Derivados de isoquinolina |
| GB0903480D0 (en) | 2009-02-27 | 2009-04-08 | Chroma Therapeutics Ltd | Enzyme Inhibitors |
| GB201211310D0 (en) | 2012-06-26 | 2012-08-08 | Chroma Therapeutics Ltd | CSF-1R kinase inhibitors |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| BR112015008167B1 (pt) | 2012-10-17 | 2020-11-17 | Macrophage Pharma Limited | composto, composição farmacêutica, métodos para a inibição da atividade de uma enzima quinase map p38, para o tratamento ou a prevenção de doença autoimune ou inflamatória em um indivíduo, e para o tratamento, a melhoria ou a redução da incidência de doença proliferativa de células em um indivíduo, uso de composto, e, ácido |
| GB201306901D0 (en) * | 2013-04-16 | 2013-05-29 | Chroma Therapeutics Ltd | Combination |
| WO2015153683A1 (en) | 2014-04-02 | 2015-10-08 | Intermune, Inc. | Anti-fibrotic pyridinones |
| GB201713975D0 (en) | 2017-08-31 | 2017-10-18 | Macrophage Pharma Ltd | Medical use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0308429A (pt) * | 2002-03-14 | 2005-01-11 | Bayer Healthcare Ag | Aroilpiridinonas monocìclicas como agentes antiinflamatórios |
| PL1877098T3 (pl) * | 2005-05-05 | 2013-09-30 | Glaxosmithkline Ip Dev Ltd | Koniugaty estru alfa-aminokwasu z lekiem ulegające hydrolizie z udziałem karboksyloesterazy |
| EP2245012B1 (en) * | 2008-02-29 | 2013-07-03 | Chroma Therapeutics Limited | Inhibitors of p38 map kinase |
-
2007
- 2007-05-01 WO PCT/GB2007/001596 patent/WO2007129040A1/en not_active Ceased
- 2007-05-01 CN CN201210457450.4A patent/CN102942520B/zh not_active Expired - Fee Related
- 2007-05-01 DK DK07732629.6T patent/DK2013175T5/da active
- 2007-05-01 AU AU2007246869A patent/AU2007246869B2/en not_active Ceased
- 2007-05-01 JP JP2009508455A patent/JP5340918B2/ja not_active Expired - Fee Related
- 2007-05-01 PT PT77326296T patent/PT2013175T/pt unknown
- 2007-05-01 CA CA2650970A patent/CA2650970C/en not_active Expired - Fee Related
- 2007-05-01 ES ES07732629.6T patent/ES2605727T3/es active Active
- 2007-05-01 KR KR1020087029538A patent/KR101429780B1/ko not_active Expired - Fee Related
- 2007-05-01 HU HUE07732629A patent/HUE033281T2/en unknown
- 2007-05-01 US US12/299,333 patent/US8044211B2/en not_active Expired - Fee Related
- 2007-05-01 EP EP07732629.6A patent/EP2013175B9/en not_active Not-in-force
- 2007-05-01 NZ NZ573348A patent/NZ573348A/en not_active IP Right Cessation
- 2007-05-01 BR BRPI0711310A patent/BRPI0711310B8/pt not_active IP Right Cessation
-
2017
- 2017-01-02 CY CY20171100002T patent/CY1118518T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102942520A (zh) | 2013-02-27 |
| CA2650970C (en) | 2014-09-16 |
| CA2650970A1 (en) | 2007-11-15 |
| BRPI0711310B1 (pt) | 2020-12-15 |
| BRPI0711310A2 (pt) | 2011-12-06 |
| ES2605727T9 (es) | 2020-12-11 |
| ES2605727T3 (es) | 2017-03-16 |
| KR101429780B1 (ko) | 2014-08-18 |
| EP2013175B1 (en) | 2016-11-09 |
| HUE033281T2 (en) | 2017-11-28 |
| AU2007246869A1 (en) | 2007-11-15 |
| KR20090014187A (ko) | 2009-02-06 |
| EP2013175B9 (en) | 2020-11-11 |
| NZ573348A (en) | 2012-01-12 |
| PT2013175T (pt) | 2017-02-14 |
| DK2013175T3 (en) | 2017-02-20 |
| AU2007246869B2 (en) | 2012-10-18 |
| US20090099185A1 (en) | 2009-04-16 |
| WO2007129040A1 (en) | 2007-11-15 |
| EP2013175A1 (en) | 2009-01-14 |
| CY1118518T1 (el) | 2017-07-12 |
| JP2009535385A (ja) | 2009-10-01 |
| US8044211B2 (en) | 2011-10-25 |
| JP5340918B2 (ja) | 2013-11-13 |
| DK2013175T5 (da) | 2020-12-21 |
| CN102942520B (zh) | 2015-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0711310B8 (pt) | composto inibidor de p38 map cinase, composição farmacêutica compreendendo o mesmo e uso do mesmo | |
| ZA202007843B (en) | Tertiary amine substituted coumarin compounds and their uses as fluorescent labels | |
| ECSP055910A (es) | Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion | |
| CY1108445T1 (el) | Νεα μεθοδος συνθεσης και νεα κρυσταλλικη μορφη της αγομελατινης καθως και φαρμακευτικες συνθεσεις που την περιεχουν | |
| AR082109A1 (es) | Derivados de bipiridilo | |
| EA201071232A1 (ru) | Триазины как ингибиторы киназы pi3 и mtor | |
| PE20151764A1 (es) | Derivados de pirrolo[2,3-d]pirimidina | |
| EA201190099A1 (ru) | (1-фенил-2-пиридин-4-ил)этиловые эфиры бензойной кислоты в качестве ингибиторов фосфодиэстеразы | |
| EA201100189A1 (ru) | Гетероарильные производные в качестве ингибиторов dgat1 | |
| BRPI1009333B8 (pt) | compostos inibidores de beta-secretase, seus usos, bem como composição farmacêutica | |
| ATE484504T1 (de) | Imidazo ä1,2-aüpyridin-2-carboxamid-derivate, herstellungsverfahren und ihre verwendung für therapeutika | |
| BR112014009102A2 (pt) | compostos químicos | |
| ECSP088765A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes | |
| PE20070593A1 (es) | Compuestos pirrolopirimidina como inhibidores de syk | |
| PE20140970A1 (es) | Derivados de 6-ciclobutil-1,5-dihidro-pirazol [3,4-d) pirimidin-4-ona y su uso como inhibidores de pde9a | |
| CY1111269T1 (el) | Ρυθμιστες βενζιμιδαζολης του vr1 | |
| WO2009109991A3 (en) | Novel hydrazide containing tyrosine kinase inhibitors | |
| UY30104A1 (es) | Derivados nuevos de urea ciclica, su preparacinn y su utilizacinn farmacéutica como inhibidores de cinasas | |
| ECSP056232A (es) | Nuevos compuestos | |
| MX2010003849A (es) | Antagonistas de cgrp. | |
| BRPI0810661A2 (pt) | [2,6] naftiridinas úteis como inibidoras de quinase proteica. | |
| BRPI0809542A8 (pt) | Compostos derivados de indol tendo atividade de inibição de cpla2, composição farmacêutica, e métodos de produção dos referidos compostos | |
| EA201170224A1 (ru) | Новые производные имидазо[1,2-a]пиримидинов, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и новое применение, в частности, в качестве ингибиторов мет | |
| CO6280421A2 (es) | Bifosfatos de alquilo de 2 a 5 atomos de carbonoimidazol | |
| PE20050312A1 (es) | Compuestos de peptidilo como inhibidores de catepsina s |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: MACROPHAGE PHARMA LIMITED (GB) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/05/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2721 DE 28-02-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |